| 1. | Finasteride use was greater among cases than controls
病例组中使用非那雄胺者多于对照组。 |
| 2. | Finasteride was associated with an increased cap risk
非那雄胺与患前列腺癌的危险性增高有关。 |
| 3. | Determination of finasteride by single - sweeping oscillopolarography
单扫描示波极谱法测定非那雄胺 |
| 4. | This risk of advanced cap was not affected by finasteride
发生进展期前列腺癌的危险性不受非那雄胺的影响。 |
| 5. | Finasteride use for less than 4 years was associated with an increased risk for localized cap
服用非那雄胺不足4年与发生局限性前列腺癌的危险性增加有关。 |
| 6. | Prostate cancer preention trial begins , testing finasteride , a drug used to reduce symptoms of prostate enlargement
前列腺癌预防试验开始,验证减轻前列腺肥大症状的药物非那雄胺的预防作用 |
| 7. | Only one product besides rogaine has been proven in controlled clinical studies to stop hair loss and regrow new hair : propecia ? tablets ( finasteride )
除落建之外，只有保法止片剂（非那雄胺）被临床证明能阻止脱发并再生新发。 |
| 8. | This is the first study to evaluate cap risk among finasteride users in a population - based setting and compare it to that of alpha - blocker users
这项研究首次在全人群病例中研究非那雄胺使用者中前列腺癌的危险性，并与阻滞剂使用这对比。 |
| 9. | They state that the cap risk in symptomatic finasteride users is strongly affected by not only the biological effect of finasteride , but by the clinical practices and diagnostics in the management of bph
他们认为，在症状性非那雄胺使用者中，前列腺癌的危险性不仅仅受非那雄胺生物学效应的显著影响，也受临床实践和前列腺增生治疗中的诊断学影响。 |
